- Home>
- Journal Watch
- >
- uterine cancer
Search for uterine cancer in all Journal Watch editions
Physician-authored summaries on the latest research on uterine cancer, editorials on uterine cancer, and perspectives on uterine cancer - drawn from the top medical journals.
Sort by:
Items 1 to 12 of 12 results - Relevance
- Date
You searched for: uterine cancer
-
Raloxifene vs. Tamoxifen: Breast Cancer and Other Outcomes in the STAR Trial
- July 13, 2006
- Andrew M. Kaunitz, MD
- Women's Health
Few clinical or quality-of-life differences emerged between raloxifene and tamoxifen in this study of breast cancer prevention in high-risk women.- Reviewing:
- Vogel VG et al., JAMA 2006 Jun 21; 295:2727-41. Land SR et al., JAMA 2006 Jun 21; 295:2742-51. Gradishar WJ and Cella D., JAMA 2006 Jun 21; 295:2784-6.
-
ASCO 2008 Report: Gynecologic Cancer Free
- July 22, 2008
- Oncology and Hematology
New therapies for endometrial, cervical, and ovarian cancers include monoclonal antibodies and unique platinum-based regimens. -
Ultrasound of Little Value in Identifying Early-Stage Ovarian Cancer
- May 13, 2005
- Robert W. Rebar, MD
- General Medicine
Ovarian cancer claims more lives in the U.S. each year than all other gynecologic malignancies combined, mainly because we lack effective methods for early detection. . . .- Reviewing:
- Fishman DA et al., Am J Obstet Gynecol 2005 Apr; 192:1214-22.
-
Sentinel Node Biopsy for Early-Stage Endometrial Cancer?
- May 24, 2011
- Matthew P. Schlumbrecht, MD, MPH, and Pedro T. Ramirez, MD
- Oncology and Hematology
A multicenter prospective trial offers supportive data, but concerns persist.- Reviewing:
- Ballester M et al., Lancet Oncol 2011 May; 12:469.
-
Tamoxifen vs. Raloxifene in Preventing Breast Cancer Free
- April 20, 2010
- Physician's First Watch
Tamoxifen appears to be superior to raloxifene in primary prevention of invasive breast cancer, but it comes at the cost of higher toxicity, according to... -
Tamoxifen for Breast Cancer Prevention: Extended Follow-Up
- December 20, 2005
- Allan S. Brett, MD
- General Medicine
Updated findings from the U.S. Breast Cancer Prevention Trial are in.- Reviewing:
- Fisher B et al., J Natl Cancer Inst 2005 Nov 16; 97:1652-62.
-
Surgery for Weight Loss: Effects on the Reproductive Health of Women
- March 9, 2005
- Dorothy Roedel Ferraro, MS, CS, ANP, CNOR, RNFA
- Women's Health
Clinicians are being faced with increasing numbers of women undergoing surgical procedures for the treatment of severe obesity. Patients who are considering weight-loss surgery must . . . -
Estrogen Plus Progestin Doesn't Protect Against Gynecologic Cancers
- October 24, 2003
- Robert W. Rebar, MD
- General Medicine
To examine the effects of continuous combined hormone therapy (HT) on gynecologic cancers, investigators analyzed data from the Women's Health Initiative (WHI). During a mean . . .- Reviewing:
- Anderson GL et al., JAMA 2003 Oct 1; 290:1739-48.
-
Do Fertility Drugs Increase Risk for Cancer in IVF Patients?
- February 1, 2000
- MA Shepard
- Women's Health
Women seeking in vitro fertilization (IVF) may take high dosages of fertility drugs to promote superovulation for egg harvest. Concern has developed that these drugs . . .- Reviewing:
- Venn A et al., Lancet 1999 Nov 6; 354:
1586 1590 . Rossing MA and Daling JR., Lancet 1999 Nov 6; 354:1573 1574 .
-
ERT AND CAD: SURPRISING RESULTS FROM POOLED DATA.
- August 15, 1997
- KI Marton
- General Medicine
The belief that estrogen replacement therapy (ERT) lowers the risk for cardiovascular events is based primarily on randomized trials that examine biologic markers of CAD . . .- Reviewing:
- Hemminki H and McPherson K., BMJ 1997 Jul 19; 315:
149 153 .
-
FUO in a 56-Year-Old Woman
- June 1, 1997
- Roy M. Gulick, MD
- HIV/AIDS
Artemis G. was born in Puerto Rico, and came to the United States at age 19. Now 56 years old, she presents for hospital admission . . . -
ADDING PROGESTERONE TO ESTROGEN OK FOR THE HEART.
- March 22, 1996
- KI Marton
- General Medicine
Growing evidence indicates that estrogen replacement therapy protects against ischemic heart disease (IHD). Although progestational agents are often added to prevent the risk of uterine . . .- Reviewing:
- Medical Research council's general practice framework., BMJ 1996 Feb 24; 312:
473 478 .
- Prev
- 1
- Next
Sort by:
Items 1 to 12 of 12 results - Relevance
- Date
